UNSPSC 51391800: Sympathomimetic or adrenergic amphetamines

Sympathomimetic or adrenergic drugs made from a powerful central nervous system stimulant and Phenethylamine.

UNSPSC 51391800 Sympathomimetic or adrenergic amphetamines is a Class code that covers pharmaceutical procurement by state and local health and public-safety agencies, though recent solicitation activity shows a significant mismatch between the code's nominal scope and actual buying patterns. Seminole County, Florida, which posted the only recent opportunity under this code, is procuring naloxone and safe drug deactivation systems—both harm-reduction and overdose-response products—rather than sympathomimetic or adrenergic amphetamines. Naloxone is an opioid antagonist used to reverse opioid overdoses, and drug deactivation systems are designed to safely neutralize illicit substances, neither of which aligns with the code's stated category of stimulant pharmaceuticals. The procurement is structured as a competitive IFB with an initial two-year term and one-year renewal option, requiring quarterly deliveries to the Seminole County Community Health Building and compliance with E-Verify, drug-free workplace certification, and federal regulations including the Clean Air Act and Federal Water Pollution Control Act; bidders must provide unit costs and carry workers' compensation, commercial general liability, and professional liability insurance.

This code shows minimal recent activity and little decision-relevant signal for business development targeting state and local procurement. The single identified opportunity originates from Seminole County, Florida and closed in July 2026. The mismatch between the code's pharmaceutical classification (sympathomimetic amphetamines) and the actual scope of work (naloxone and drug deactivation systems) suggests either miscoding by the issuing body or a category drift in how the code is being applied in practice. Vendors pursuing state and local procurement in pharmaceutical or public-health categories should verify code alignment through pre-bid inquiry or direct contact with issuing agencies before investing in bid preparation, as this code does not reliably predict the nature of pharmaceutical or health-related goods being solicited.